Privia Health Group, Inc. (PRVA)
NASDAQ: PRVA · Real-Time Price · USD
23.84
-0.16 (-0.67%)
Dec 5, 2025, 4:00 PM EST - Market closed
Privia Health Group Stock Forecast
Stock Price Forecast
According to 14 professional analysts, the 12-month price target for Privia Health Group stock ranges from a low of $23 to a high of $36. The average analyst price target of $30.07 forecasts a 26.13% increase in the stock price over the next year.
Price Target: $30.07 (+26.13%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Privia Health Group stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 9 | 9 | 9 | 9 | 9 | 9 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Buy Reiterates $32 | Buy | Reiterates | $32 | +34.23% | Dec 4, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $32 → $33 | Buy | Maintains | $32 → $33 | +38.42% | Nov 13, 2025 |
| BMO Capital | BMO Capital | Buy Initiates $30 | Buy | Initiates | $30 | +25.84% | Nov 13, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $32 → $34 | Strong Buy | Maintains | $32 → $34 | +42.62% | Nov 12, 2025 |
| Barclays | Barclays | Hold Maintains $22 → $23 | Hold | Maintains | $22 → $23 | -3.52% | Nov 10, 2025 |
Financial Forecast
Revenue This Year
3.53B
from 1.74B
Increased by 103.35%
Revenue Next Year
3.87B
from 3.53B
Increased by 9.63%
EPS This Year
0.14
from 0.11
Increased by 23.86%
EPS Next Year
0.32
from 0.14
Increased by 136.80%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.7B | 4.1B | ||||
| Avg | 3.5B | 3.9B | ||||
| Low | 3.2B | 3.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 111.3% | 15.5% | ||||
| Avg | 103.4% | 9.6% | ||||
| Low | 86.9% | -0.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.17 | 0.45 | |
| Avg | 0.14 | 0.32 | |
| Low | 0.06 | 0.14 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 52.7% | 231.4% | |
| Avg | 23.9% | 136.8% | |
| Low | -46.5% | 0.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.